Effect and mechanism of thrombospondin-1 on the angiogenesis potential in human endothelial progenitor cells: An in vitro study

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Qin, Qing ^a   Qian, Juying ^a   Ge, Lei ^a   Shen, Li ^a   Jia, Jianguo ^a   Jin, Jianhao ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD47; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ANTIANGIOGENIC ACTIVITY; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DOSE RESPONSE; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PHARMACOLOGICAL BLOCKING; PROTEIN PHOSPHORYLATION; RENTROP GRADING SYSTEM; UMBILICAL CORD BLOOD;

ADULT; AGED; ANTIGENS, CD47; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; THROMBOSPONDIN 1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84895511370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088213     Document Type: Article

References (40)

1. Meier P, Schirmer SH, Lansky AJ, Timmis A, Pitt B, et al. (2013) The collateral circulation of the heart. BMC Med 11: 143.
2. Tongers J, Roncalli JG, Losordo DW (2010) Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res 79: 200-206.
3. Kanzler I, Tuchscheerer N, Steffens G, Simsekyilmaz S, Konschalla S, et al. (2013) Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis. Basic Res Cardiol 108: 310.
4. Shao H, Tan Y, Eton D, Yang Z, Uberti MG, et al. (2008) Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells 26: 1376-1384.
5. Lawler JW, Slayter HS, Coligan JE (1978) Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 253: 8609-8616. (Pubitemid 9082569)
6. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, et al. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A 87: 6624-6628.
7. Esemuede N, Lee T, Pierre-Paul D, Sumpio BE, Gahtan V (2004) The role of thrombospondin-1 in human disease. J Surg Res 122: 135-142. (Pubitemid 39441244)
8. Uronis HE, Cushman SM, Bendell JC, Blobe GC, Morse MA, et al. (2013) A phase I study of ABT-510 plus bevacizumab in advanced solid tumors. Cancer Med 2: 316-324.
9. Sahora AI, Rusk AW, Henkin J, McKeegan EM, Shi Y, et al. (2012) Prospective study of thrombospondin-1 mimetic peptides, ABT-510 and ABT-898, in dogs with soft tissue sarcoma. J Vet Intern Med 26: 1169-1176.
10. Nabors LB, Fiveash JB, Markert JM, Kekan MS, Gillespie GY, et al. (2010) A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma. Arch Neurol 67: 313-319.
11. Frangogiannis NG (2012) Matricellular proteins in cardiac adaptation and disease. Physiol Rev 92: 635-688.
12. Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG (2010) The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 48: 504-511.
13. Carlson CB, Lawler J, Mosher DF (2008) Structures of thrombospondins. Cell Mol Life Sci 65: 672-686.
14. Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD (2009) Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 9: 182-194.
15. Lawler PR, Lawler J (2012) Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med 2: a006627.
16. Dawson DW, Pearce SF, Zhong R, Silverstein RL, Frazier WA, et al. (1997) CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 138: 707-717. (Pubitemid 27349849)
17. Short SM, Derrien A, Narsimhan RP, Lawler J, Ingber DE, et al. (2005) Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins. J Cell Biol 168: 643-653. (Pubitemid 40271029)
18. Roberts DD, Isenberg JS, Ridnour LA, Wink DA (2007) Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis. Clin Cancer Res 13: 795-798. (Pubitemid 46340351)
19. Rentrop KP, Cohen M, Blanke H, Phillips RA (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5: 587-592. (Pubitemid 15141963)
20. Bompais H, Chagraoui J, Canron X, Crisan M, Liu XH, et al. (2004) Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 103: 2577-2584. (Pubitemid 38393010)
21. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, et al. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288-293. (Pubitemid 38197580)
22. Mukai N, Akahori T, Komaki M, Li Q, Kanayasu-Toyoda T, et al. (2008) A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp Cell Res 314: 430-440.
23. Nguyen VA, Furhapter C, Obexer P, Stossel H, Romani N, et al. (2009) Endothelial cells from cord blood CD133+CD34+ progenitors share phenotypic, functional and gene expression profile similarities with lymphatics. J Cell Mol Med 13: 522-534.
24. Smadja DM, d'Audigier C, Bieche I, Evrard S, Mauge L, et al. (2011) Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol 31: 551-559.
25. Aburakawa Y, Kawabe J, Okada M, Yamauchi A, Asanome A, et al. (2013) Prostacyclin stimulated integrin-dependent angiogenic effects of endothelial progenitor cells and mediated potent circulation recovery in ischemic hind limb model. Circ J 77: 1053-1062.
26. Kaur S, Martin-Manso G, Pendrak ML, Garfield SH, Isenberg JS, et al. (2010) Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J Biol Chem 285: 38923-38932.
27. Primo L, Ferrandi C, Roca C, Marchio S, di Blasio L, et al. (2005) Identification of CD36 molecular features required for its in vitro angiostatic activity. FASEB J 19: 1713-1715. (Pubitemid 41429539)
28. Dias JV, Benslimane-Ahmim Z, Egot M, Lokajczyk A, Grelac F, et al. (2012) A motif within the N-terminal domain of TSP-1 specifically promotes the proangiogenic activity of endothelial colony-forming cells. Biochem Pharmacol 84: 1014-1023.
29. Zhang X, Kazerounian S, Duquette M, Perruzzi C, Nagy JA, et al. (2009) Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J 23: 3368-3376.
30. Isenberg JS, Jia Y, Fukuyama J, Switzer CH, Wink DA, et al. (2007) Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. J Biol Chem 282: 15404-15415. (Pubitemid 47093297)
31. Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, et al. (2006) CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 281: 26069-26080. (Pubitemid 44401813)
32. Bauer EM, Qin Y, Miller TW, Bandle RW, Csanyi G, et al. (2010) Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res 88: 471-481.
33. Isenberg JS, Romeo MJ, Maxhimer JB, Smedley J, Frazier WA, et al. (2008) Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease. Ann Surg 247: 860-868. (Pubitemid 351591523)
34. Isenberg JS, Romeo MJ, Yu C, Yu CK, Nghiem K, et al. (2008) Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 111: 613-623.
35. Tokgozoglu L, Yorgun H, Gurses KM, Canpolat U, Ates AH, et al. (2011) The association between circulating endothelial progenitor cells and coronary collateral formation. Atherosclerosis 219: 851-854.
36. Werner GS, Jandt E, Krack A, Schwarz G, Mutschke O, et al. (2004) Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation 110: 1940-1945. (Pubitemid 39331905)
37. Schirmer SH, van Royen N, Moerland PD, Fledderus JO, Henriques JP, et al. (2009) Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans. J Am Coll Cardiol 53: 2141-2147.
38. de Boer HC, Verseyden C, Ulfman LH, Zwaginga JJ, Bot I, et al. (2006) Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol 26: 1653-1659. (Pubitemid 44288997)
39. Mause SF, Ritzel E, Liehn EA, Hristov M, Bidzhekov K, et al. (2010) Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 122: 495-506.
40. Italiano JE, Jr., Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, et al. (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111: 1227-1233. (Pubitemid 351213404)